GANX vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

GANX

56.4
AI Score
VS
GANX Wins

CLYM

29.1
AI Score

Investment Advisor Scores

GANX

56score
Recommendation
HOLD

CLYM

29score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric GANX CLYM Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -100.0% 0.0% CLYM
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 56.4/100 29.1/100 GANX
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY GANX

Relative Price Performance (Last 90 Days)

GANX 1M: -18.2% · 3M: -49.1% CLYM 1M: +5.6% · 3M: -33.4%

Current Technical Phase

GANX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -17.4%), weak momentum, RSI 36

RSI (14): 36.2 · Price: $1.08

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.9 · Price: $10.87

Fundamentals Snapshot

Metric GANX CLYM
Market Cap — —
Forward P/E -1.6 -10.9
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -1.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -0.50 -0.81
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GANX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.